Skip to content
Menu

BioStem Technologies, Inc. BSEM

Full chart Compare
Set alert

Price alert · BSEM

All alert types
0.71 USD -0.11 (-13.53%)

Regular-session close

0.73 +0.02 +3.18%

Pre-market · Nov 20, 8:46 AM ET

0.7001 Day range 0.94
0.70 52-week range 8.40
YTD
-81.43%
1 year
-81.13%

Fundamental scorecard

2 of 25 checks passed on BSEM’s reported financials

ValueGrowthProfitabilityHealthDividend

2of 25 checks passed

  • Value 0 of 5
  • Growth No data
  • Profitability No data
  • Financial health 2 of 5
  • Dividend No data

Statements to Sep 30, 2026.

Value 0 of 5

  • Failed:P/E below its own 5-year median Not enough data to decide.
  • No data:P/E under 20 Not enough data to decide.
  • Failed:Price to sales below its own 5-year median Not enough data to decide.
  • No data:Price to book below its own 5-year median Price to book 0.7. Not enough data to decide.
  • No data:Free cash flow yield above 4% Not enough data to decide.

Growth No data

  • No data:Revenue grew over the last year Not enough data to decide.
  • No data:Revenue grew more than 5% a year over five years Not enough data to decide.
  • No data:Earnings per share grew over the last year Not enough data to decide.
  • No data:Earnings per share grew more than 5% a year over five years Not enough data to decide.
  • No data:Analysts expect higher earnings per share over the next year No analyst estimate.

Profitability No data

  • No data:Profitable over the last year Not enough data to decide.
  • No data:Profitable in each of the last five fiscal years Not enough data to decide.
  • No data:Return on equity above 15% Not enough data to decide.
  • No data:Net margin above its 5-year average Not enough data to decide.
  • No data:Free cash flow is at least 80% of net income Not enough data to decide.

Financial health 2 of 5

  • Failed:Short-term assets cover short-term liabilities Short-term assets of 16.1M against short-term liabilities of 22.2M.
  • Passed:Short-term assets cover long-term liabilities Short-term assets of 16.1M against long-term liabilities of 3.08M.
  • Passed:Net debt under 40% of equity Net debt of 195K is 1.1% of equity.
  • No data:Operating cash flow covers at least 20% of debt Not enough data to decide.
  • No data:Operating profit covers interest at least 3 times Not enough data to decide.

Dividend No data

  • No data:Pays a dividend Not enough data to decide.
  • No data:Yield above 1.5% Not enough data to decide.
  • No data:Pays out under 75% of profit Not enough data to decide.
  • No data:Covered by free cash flow Not enough data to decide.
  • No data:Not cut in the last five fiscal years Not enough data to decide.

Mechanical checks on reported financials against fixed thresholds. They describe the numbers; they are not a recommendation to buy or sell.

Included in Essentials and up

Sign in to see Fair value

Discounted cash flow estimates against the price, and the P/E against its industry and sector.

Included in Essentials and up

Sign in to see Head count and owner earnings

Employees by annual report and the cash the business earns for its owners.

Included in Essentials and up

Sign in to see P/E against peers

The price to earnings ratio beside the closest competitors and their median.

Financial position

What BSEM owns and owes, as of Sep 30, 2026

Short term and long term

Balance sheet · 43.6M of assets

Debt, equity and cash by year

Now: 195K of debt after cash

Fiscal years, then the newest quarter. Cash includes short-term investments.

From the company’s SEC filings.

Included in Essentials and up

Sign in to see Cash flow and returns

How profit turns into free cash flow, and the returns on equity, assets and capital.

Financial health

Altman Z-Score

-3.16 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

2 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

Rating

C2 / 5 overall

  • DCF 1
  • Return on Equity 1
  • Return on Assets 1
  • Debt / Equity 4
  • P/E 1
  • P/B 3

Valuation

P/E -9.8×
P/S 1.3×
P/B 1.6×
P/FCF 9.7×
EV/EBITDA -122×
EV/Sales 0.8×
FCF Yield 10.3%

Profitability

Gross Margin 93.1%
Operating Margin -1.5%
Net Margin -13.9%
ROE -16.8%
ROIC -1.6%
ROA -13.2%

Growth (YoY)

Revenue -84.3%
Operating Income -102.2%
EPS (diluted) -126.5%
Free Cash Flow -72.6%

Financial Health

Current Ratio 4.1×
Quick Ratio 3.9×
Debt / Equity 0.1×
Net Debt / EBITDA 85.1×
Interest Coverage 0.0×

Dividends

Dividend Yield 0.0%
Payout Ratio 0.0%

Annual · latest fiscal year ends 2025-12-31